Volume 71, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


The cost of generic pentavalent antimony (generic stibogluconate) is approximately one-sixth that of branded pentavalent antimony (stibogluconate in the form of Pentostam or meglumine antimoniate in the form of Glucantime). We compared generic stibogluconate to Pentostam and Glucantime for the treatment of cutaneous leishmaniasis patients in Bolivia and Colombia. For all 114 patients, the per-protocol cure rates were 83–91% and the intent-to-treat cure rates were 75–83%. The highest values were in the generic stibogluconate group. The incidence of pancreatic enzyme abnormalities was 48–88% and the incidence of liver enzyme abnormalities was 48–87%. The lowest incidences were in the generic stibogluconate group. The efficacy and tolerance of inexpensive generic stibogluconate appears comparable to branded formulations for the treatment of cutaneous leishmaniasis in these endemic regions.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Gasser RA, Magill AJ, Oster CN, Franke ED, Grogl M, Berman JD, 1994. Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis. Clin Infect Dis 18 : 83–90. [Google Scholar]
  2. Chico ME, Guderian RH, Cooper PJ, Armijos R, Grogl M, 1995. Evaluation of a direct immunofluorescent antibody (DIFMA) test using Leishmania genus-specific monoclonal antibody in the routine diagnosis of cutaneous leishmaniasis. Rev Soc Bras Med Trop 28 : 99–103. [Google Scholar]
  3. Accessed March 2004.at http://ctep.cancer.gov/reporting/ctc.html.
  4. Velez I, Agudelo S, Hendrickx E, Puerta J, Grogl M, Modabber F, Berman J, 1997. Inefficacy of allopurinol for Colombian cutaneous leishmaniasis: a randomized, controlled trial. Ann Intern Med 126 : 232–236. [Google Scholar]
  5. Aronson NE, Wortmann GW, Johnson SC, Jackson JE, Gasser RA Jr, Magill AJ, Endy TP, Coyne PE, Grogl M, Benson PM, Beard JS, Tally JD, Gambel JM, Kreutzer RD, Oster CN, 1998. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience. Clin Infect Dis 27 : 1457–1464. [Google Scholar]
  6. Desjeux P, Mollinedo S, Le Pont F, Paredes A, Ugarte G, 1987. Cutaneous leishmaniasis in Bolivia. A study of 185 human cases from Alto Beni (La Paz Department). Isolation and iso-enzyme characterization of 26 strains of Leishmania braziliensis braziliensis. Trans R Soc Trop Med Hyg 81 : 742–746. [Google Scholar]
  7. Soto-Mancipe J, Grogl M, Berman JD, 1993. Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia. Clin Infect Dis 16 : 417–425. [Google Scholar]
  8. Grimaldi G Jr, Tesh RB, McMahon-Pratt D, 1989. A review of the geographic distribution and epidemiology of leishmaniasis in the new world. Am J Trop Med Hyg 41 : 687–725. [Google Scholar]
  9. Franke ED, Llanos-Cuentas A, Echevarria J, Cruz ME, Campos P, Tovar AA, Lucas CM, Berman JD, 1994. Efficacy of 28-day and 40-day regimens of sodium stibogluconate (Pentostam) in the treatment of mucosal leishmaniasis. Am J Trop Med Hyg 51 : 77–82. [Google Scholar]
  10. Moore E, O’Flaherty D, Heuvelmans H, Seaman J, Veeken H, de Wit S, Davidson RN, 2001. Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya. Bull World Health Organ 79 : 388–393. [Google Scholar]
  11. Ritmeijer K, Veeken H, Melaku Y, Leal G, Amsalu R, Seaman J, Davidson RN, 2001. Ethiopian visceral leishmaniasis:generic and proprietary sodim stibogluconate and equivalent: HIV co-infected patients have a poor outcome. Trans R Soc Trop Med Hyg 95 : 668–672. [Google Scholar]
  12. Veeken H, Ritmeijer K, Seaman J, Davidson R, 2000. A randomized comparison of branded sodium stibogluconate and generic sodium stibogluconate for the treatment of visceral leishmaniasis under field conditions in Sudan. Trop Med Int Health 5 : 312–317. [Google Scholar]

Data & Media loading...

  • Received : 26 Mar 2004
  • Accepted : 21 May 2004

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error